Gene Therapy Market Trends and Growth Insights 2025-2031
Gene Therapy Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Vectors (Non-Viral Vectors and Viral Vectors), Indication (Neurological Diseases, Cancer, Duchenne Muscular Dystrophy, Hepatological Diseases, and Other Indications), Delivery Mode (In-Vivo and Ex-Vivo)
- Report Date : Oct 2025
- Report Code : TIPHE100001165
- Category : Life Sciences
- Status : Published
- Available Report Formats :
- No. of Pages : 300
The Gene Therapy Market size is projected to reach US$ 12.92 billion by 2031 from US$ 5.06 billion in 2024. The market is expected to register a CAGR of 14.50% during 2025–2031.
Gene Therapy Market Analysis
The rise in chronic and genetic disease prevalence, increasing advancements in genetic engineering technologies, supportive regulatory frameworks, and increased research and development investments favor the growth of the gene therapy market. Integrating artificial intelligence (AI) into personalized medicine contributes to market development. Opportunities lie in emerging economies where disease prevalence and healthcare infrastructure are improving.
Gene Therapy Market Overview
Gene therapy is a medical approach that treats diseases by either inactivating a faulty gene, replacing it with a healthy copy, or introducing a new or modified gene into the body to help treat or prevent the condition. It can be classified into in vivo and ex vivo gene therapy. Gene therapy is used to cure cancers, neurological disorders, cardiovascular disease, infectious diseases, and rare diseases. Gene therapy encompasses the manipulation of genes to fight or prevent diseases. The therapy works by introducing a functional gene into individuals affected by a disease caused by a defective or mutated gene. Among the treatments are biosimilars, vaccines, complex generics, gene therapies, immuno-therapies, and novel drugs.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Gene Therapy Market: Strategic Insights
Market Size Value in US$ 5.11 billion in 2023 Market Size Value by US$ 25.69 billion by 2031 Growth rate CAGR of 14.3% from 2023 to 2031 Forecast Period 2023-2031 Base Year 2023
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Gene Therapy Market Drivers and Opportunities
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Gene Therapy Market: Strategic Insights
| Market Size Value in | US$ 5.11 billion in 2023 |
| Market Size Value by | US$ 25.69 billion by 2031 |
| Growth rate | CAGR of 14.3% from 2023 to 2031 |
| Forecast Period | 2023-2031 |
| Base Year | 2023 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Drivers:
Growing Prevalence Of Genetic Diseases And Cancer:
In the US, ~ 25 to 30 million individuals suffer from rare diseases, many of which are genetic and suitable for gene therapy.Advancements in Genetic Engineering Technologies:
Recent innovations in genetic engineering technologies, such as CRISPR/Cas9, base editing, and enhanced viral vectors, accelerate the development and application of therapies.Supportive Government Initiatives:
From 2024 to 2025, the FDA has expedite the approval process for cell and gene therapies, focusing on innovation and ongoing monitoring.Expanding Healthcare Infrastructure:
Research and development investments have surged, with global funding reaching billions due to public-private partnerships and grants, which have enabled over 3,000 clinical trials worldwide.Expansion of Gene Therapy CDMOs:
RoslinCT and Lykan Bioscience, prominent CDMOs in the cell and gene therapy industry, have formed a unified company operating under the RoslinCT brand.
Market Opportunities:
Expansion into Emerging Markets:
Adoption of advanced gene editing technologies, such as CRISPR and gene delivery systems, enable more effective and precise treatments. As these innovations become more accessible, they pave the way for gene therapies to address unmet medical needs, making treatment options smarter, more reliable, and more cost-effective.Personalised Medicine:
Developing treatment that can be customized for different genetic profiles supports approaches in precision medicine. Healthcare professionals can optimize treatments, cut down on wasteful spending, and make it simpler to upgrade therapeutic protocols by attending to the needs of each individual patient.R&D Activities by the Market Players:
Investing in research for gene therapy techniques that utilize non-viral delivery methods, improve safety profiles, and enhance patient outcomes provides a competitive advantage.Emerging Applications Such as Autoimmune and Solid Tumor Treatment:
The increasing demand for innovative treatments in fields such as oncology, rare genetic disorders, and chronic diseases drives growth in the gene therapy market.
Gene Therapy Market Report Segmentation Analysis
The gene therapy market is divided into different segments to give a clearer view of how it works, its growth potential, and the latest gene therapy market trends. Below is the standard segmentation approach used in industry reports:
By Vectors:
Non-Viral Vectors:
The increasing preference for non-viral vectors is influencing the dynamics of the gene therapy market by broadening its therapeutic potential.Viral Vectors:
Viral vectors derived from adeno-associated viruses (AAV), lentiviruses, adenoviruses, and retroviruses constitute the backbone of FDA-approved gene therapies.
By Indication:
Neurological Diseases:
The development of gene therapies offers potential one-time cures rather than lifelong symptom management of conditions such as neurodegenerative diseases and spinal muscular atrophy (SMA).Cancer:
The rising prevalence of cancer is increasing the demand for advanced, targeted treatments like gene therapies.Duchenne Muscular Dystrophy:
The urgency for curative options such as gene therapies, which tackle the root causes, including mutations in the dystrophin gene, rather than merely alleviating symptoms increases as the number of DMD cases growsHepatological Diseases:
Rising cases of hepatological diseases have spurred investment in the pharmaceutical sector, with companies accelerating clinical trials and regulatory submissions to seize an expanding market.Other Indications:
The increasing incidence of rare diseases propels the use of gene therapy techniques, such as antibody-drug conjugates.
By Delivery Mode:
- In-Vivo
- Ex-Vivo
By Geography:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Gene Therapy Market Report ScopeGene Therapy Market Share Analysis by Geography
The gene therapy market in Asia Pacific is witnessing the fastest growth. The need for faster order fulfilment, the booming e-commerce ecosystem, and investment in the booming e-commerce ecosystem are factors driving market expansion. Emerging markets in Latin America, the Middle East, and Africa have untapped opportunities for gene therapy providers to expand. The gene therapy market grows differently in each region. Below is a summary of market share and trends by region:
1. North America
Market Share:
Holds a significant portion of the global marketKey Drivers:
The increasing research and development of innovations contribute to the region's growing gene therapy market size. The US FDA has approved 7 cell and gene therapy drugs, with the pipeline of new products reaching ~1,200 experimental therapies. Half of these are in Phase 2 clinical trials, with estimates of annual sales growth accounting for 15% for cell therapies and ~30% for gene therapies, as per the Chemical & Engineering News report 2023 estimates.Trends:
Adoption of AI in gene editing by market players.
2. Europe
Market Share:
Substantial share due to early adoption of CRISPR/Cas9, base editing, and improved viral vector technologies.Key Drivers:
The availability of advanced research facilities and the high demand for technologically advanced genetic engineering tools for research and development of gene therapies contribute to the region's market growth.Trends:
Investments in smart gene editing solutions.
3. Asia Pacific
Market Share:
Region is fastest-growing with increasing market share each year.Key Drivers:
A strong and supportive research infrastructure and government regulations fuel the adoption of gene therapies. Countries is the region are facing a growing burden of chronic and genetic diseases, escalating the demand for innovative therapies. The rising business expansion strategies by the market players in this region are propelling the gene therapy market share.Trends:
Increasing investment in gene therapy and collaboration with CDMOs in Asia Pacific.
4. South and Central America
Market Share:
Growing market with steady progressKey Drivers:
- The increasing prevalence of genetic and rare diseases in the region is creating urgent demand for advanced therapies. Further, the government initiatives for the development of healthcare infrastructure are fueling the adoption. Fiocruz, a research foundation under the Brazilian Ministry of Health, partnered with Caring Cross in March 2024 to establish local production of CAR-T therapies. This collaboration is anticipated to reduce the cost to US$ 35,000 per dose in Brazil.
Trends:
Expanding clinical trials supporting the development of gene therapies.
5. Middle East and Africa
Market Share:
Although small, but growing quicklyKey Drivers:
- Growing investment in infrastructure under government initiatives such as the Emirati Genome Programme is vital in increasing the demand for gene therapies.
- Robust regulatory approval frameworks supporting the research and development of innovations fuel the growth of the gene therapy market.
Trends:
Public and private partnerships to adopt new gene editing technologies.
Gene Therapy Market Players Density: Understanding Its Impact on Business Dynamics
High Market Density and Competition
Competition is strong due to the presence of established players such as BEUMER Group GmbH & Co KG and Bastian Solutions LLC. Regional and niche providers such as Orchard Therapeutics (Europe), Passage Bio (US), and Yapan Bio (India) add to the competitive landscape across regions.
This high level of competition urges companies to stand out by offering:
- Advanced security features
- Value-added services such as analytics & predictive maintenance, real‑time operational analytics, and installation
- Competitive pricing models
- Strong customer support and easy integration
Opportunities and Strategic Moves
- Manufacturers and CDMOs collaborate to develop new gene therapies with advanced genetic engineering tools.
- Regulatory bodies such as the US FDA, Canada Health, and ANVISA have streamlined the approval process for the fast and easy launch of innovations.
- Academic and research institutes are expanding research capabilities with government grants and funds.
Additional companies analyzed during the course of research:
- Intellia Therapeutics
- Sana Biotechnology
- Caribou Biosciences
- Editas Medicine
- Beam Therapeutics
- Sangamo Therapeutics
- Freeline
- Orchard Therapeutics
- uniQure
- Pfizer
- Takara Bio Inc
- PTC Therapeutics
- Adaptimmune Therapeutics
- Adverum Biotechnologies
- Bayer
- eGenesis
Gene Therapy Market News and Recent Developments
AGC Biologics Launched a New Dedicated Cell and Gene Business Division.
The new Cell and Gene Technologies Division launched byAGC Biologics will focus on elevating AGC Biologics’ existing capabilities and supporting developers who need capacity, scientific capabilities, and technically qualified cell and gene CDMO operators. The site offers 30 years of experience in cell and gene therapy, with nine commercial approvals and hundreds of GMP batches produced successfullyFDA Approved Casgevy and Lyfgenia to Treat Patients with Sickle Cell Disease
Casgevy is the first FDA-approved therapy utilizing CRISPR/Cas9, a genome editing technology. Patients’ hematopoietic (blood) stem cells are modified by genome editing using CRISPR/Cas9 technology.
Gene Therapy Market Report Coverage and Deliverables
The "Gene Therapy Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:
- Gene Therapy Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Gene Therapy Market trends, as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST and SWOT analysis
- Gene Therapy Market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the gene therapy Market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Vectors, Indication, Delivery Mode, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Novartis AG; Astellas Pharma Inc; Bristol-Myers Squibb Co, Bluebird Bio Inc, PTC Therapeutics, Inc, Sanofi SA, Daiichi Sankyo Co Ltd, CSL Behring LLC, BioMarin Pharmaceutical Inc., and Vertex Pharmaceuticals Inc are among the key players operating in the gene therapy market.
The rising rare and genetic diseases and advancements in genetic engineering technologies are noteworthy factors contributing to the market growth.
North America dominated the market in 2024.
The gene therapy market is estimated to register a CAGR of 14.5% during the forecast period.
The gene therapy market is estimated to reach US$ 12.92 billion by 2031.
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Analyst Market Outlook
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
3.3 Assumptions and Limitations
4. Gene Therapy Market Landscape
4.1 Overview
4.2 PEST Analysis
5. Gene Therapy Market – Key Market Dynamics
5.1 Gene Therapy Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Rising Prevalence of Genetic and Chronic Diseases
5.2.2 Advancements in Genetic Engineering Technologies
5.2.3 Supportive Regulatory Frameworks and Increased Research and Development Investments
5.3 Market Restraints
5.3.1 High Costs and Affordability Issues
5.3.2 Regulatory Hurdles and Funding Barriers
5.3.3 Manufacturing and Scalability Challenges
5.4 Market Opportunities
5.4.1 Expansion into Emerging Markets
5.4.2 Innovations in Cost-Reduction for Manufacturing
5.4.3 Application to Autoimmune and Solid Tumor Treatments
5.5 Future Trends
5.5.1 Integration of Artificial Intelligence
5.5.2 Advancements in In Vivo Delivery and Nucleic Acid Designs
5.5.3 Focus on Non-Coding RNAs and NGS-Based Diagnostics
5.6 Impact of Drivers and Restraints:
6. Gene Therapy Market – Global Market Analysis
6.1 Gene Therapy Market Revenue (US$ Million), 2021–2031
6.2 Gene Therapy Market Forecast Analysis
7. Gene Therapy Market Analysis – by Vector
7.1 Non-Viral Vectors
7.1.1 Overview
7.1.2 Non-Viral Vectors: Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Viral Vectors
7.2.1 Overview
7.2.2 Viral Vectors: Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
8. Gene Therapy Market Analysis – by Indications
8.1 Neurological Diseases
8.1.1 Overview
8.1.2 Neurological Diseases: Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Cancer
8.2.1 Overview
8.2.2 Cancer: Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Duchenne Muscular Dystrophy
8.3.1 Overview
8.3.2 Duchenne Muscular Dystrophy: Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Hepatological Diseases
8.4.1 Overview
8.4.2 Hepatological Diseases: Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
8.5 Other Indications
8.5.1 Overview
8.5.2 Other Indications: Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
9. Gene Therapy Market Analysis – by Delivery Mode
9.1 In-Vivo
9.1.1 Overview
9.1.2 In-Vivo: Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Ex-Vivo
9.2.1 Overview
9.2.2 Ex-Vivo: Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
10. Gene Therapy Market – Geographical Analysis
10.1 Overview
10.2 North America
10.2.1 North America Gene Therapy Market Overview
10.2.2 North America: Gene Therapy Market – Revenue, 2021–2031 (US$ Million)
10.2.3 North America: Gene Therapy Market Breakdown, by Vector
10.2.3.1 North America: Gene Therapy Market – Revenue and Forecast Analysis – by Vector
10.2.4 North America: Gene Therapy Market Breakdown, by Indications
10.2.4.1 North America: Gene Therapy Market – Revenue and Forecast Analysis – by Indications
10.2.5 North America: Gene Therapy Market Breakdown, by Delivery Mode
10.2.5.1 North America: Gene Therapy Market – Revenue and Forecast Analysis – by Delivery Mode
10.2.6 North America: Gene Therapy Market – Revenue and Forecast Analysis – by Country
10.2.6.1 North America: Gene Therapy Market – Revenue and Forecast Analysis – by Country
10.2.6.2 United States: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.2.6.2.1 United States: Gene Therapy Market Breakdown, by Vector
10.2.6.2.2 United States: Gene Therapy Market Breakdown, by Indications
10.2.6.2.3 United States: Gene Therapy Market Breakdown, by Delivery Mode
10.2.6.3 Canada: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.2.6.3.1 Canada: Gene Therapy Market Breakdown, by Vector
10.2.6.3.2 Canada: Gene Therapy Market Breakdown, by Indications
10.2.6.3.3 Canada: Gene Therapy Market Breakdown, by Delivery Mode
10.2.6.4 Mexico: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.2.6.4.1 Mexico: Gene Therapy Market Breakdown, by Vector
10.2.6.4.2 Mexico: Gene Therapy Market Breakdown, by Indications
10.2.6.4.3 Mexico: Gene Therapy Market Breakdown, by Delivery Mode
10.3 Europe
10.3.1 Europe Gene Therapy Market Overview
10.3.2 Europe: Gene Therapy Market – Revenue, 2021–2031 (US$ Million)
10.3.3 Europe: Gene Therapy Market Breakdown, by Vector
10.3.3.1 Europe: Gene Therapy Market – Revenue and Forecast Analysis – by Vector
10.3.4 Europe: Gene Therapy Market Breakdown, by Indications
10.3.4.1 Europe: Gene Therapy Market – Revenue and Forecast Analysis – by Indications
10.3.5 Europe: Gene Therapy Market Breakdown, by Delivery Mode
10.3.5.1 Europe: Gene Therapy Market – Revenue and Forecast Analysis – by Delivery Mode
10.3.6 Europe: Gene Therapy Market – Revenue and Forecast Analysis – by Country
10.3.6.1 Europe: Gene Therapy Market – Revenue and Forecast Analysis – by Country
10.3.6.2 United Kingdom: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.3.6.2.1 United Kingdom: Gene Therapy Market Breakdown, by Vector
10.3.6.2.2 United Kingdom: Gene Therapy Market Breakdown, by Indications
10.3.6.2.3 United Kingdom: Gene Therapy Market Breakdown, by Delivery Mode
10.3.6.3 Germany: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.3.6.3.1 Germany: Gene Therapy Market Breakdown, by Vector
10.3.6.3.2 Germany: Gene Therapy Market Breakdown, by Indications
10.3.6.3.3 Germany: Gene Therapy Market Breakdown, by Delivery Mode
10.3.6.4 France: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.3.6.4.1 France: Gene Therapy Market Breakdown, by Vector
10.3.6.4.2 France: Gene Therapy Market Breakdown, by Indications
10.3.6.4.3 France: Gene Therapy Market Breakdown, by Delivery Mode
10.3.6.5 Spain: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.3.6.5.1 Spain: Gene Therapy Market Breakdown, by Vector
10.3.6.5.2 Spain: Gene Therapy Market Breakdown, by Indications
10.3.6.5.3 Spain: Gene Therapy Market Breakdown, by Delivery Mode
10.3.6.6 Italy: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.3.6.6.1 Italy: Gene Therapy Market Breakdown, by Vector
10.3.6.6.2 Italy: Gene Therapy Market Breakdown, by Indications
10.3.6.6.3 Italy: Gene Therapy Market Breakdown, by Delivery Mode
10.3.6.7 Rest of Europe: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.3.6.7.1 Rest of Europe: Gene Therapy Market Breakdown, by Vector
10.3.6.7.2 Rest of Europe: Gene Therapy Market Breakdown, by Indications
10.3.6.7.3 Rest of Europe: Gene Therapy Market Breakdown, by Delivery Mode
10.4 Asia Pacific
10.4.1 Asia Pacific Gene Therapy Market Overview
10.4.2 Asia Pacific: Gene Therapy Market – Revenue, 2021–2031 (US$ Million)
10.4.3 Asia Pacific: Gene Therapy Market Breakdown, by Vector
10.4.3.1 Asia Pacific: Gene Therapy Market – Revenue and Forecast Analysis – by Vector
10.4.4 Asia Pacific: Gene Therapy Market Breakdown, by Indications
10.4.4.1 Asia Pacific: Gene Therapy Market – Revenue and Forecast Analysis – by Indications
10.4.5 Asia Pacific: Gene Therapy Market Breakdown, by Delivery Mode
10.4.5.1 Asia Pacific: Gene Therapy Market – Revenue and Forecast Analysis – by Delivery Mode
10.4.6 Asia Pacific: Gene Therapy Market – Revenue and Forecast Analysis – by Country
10.4.6.1 Asia Pacific: Gene Therapy Market – Revenue and Forecast Analysis – by Country
10.4.6.2 China: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.4.6.2.1 China: Gene Therapy Market Breakdown, by Vector
10.4.6.2.2 China: Gene Therapy Market Breakdown, by Indications
10.4.6.2.3 China: Gene Therapy Market Breakdown, by Delivery Mode
10.4.6.3 Japan: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.4.6.3.1 Japan: Gene Therapy Market Breakdown, by Vector
10.4.6.3.2 Japan: Gene Therapy Market Breakdown, by Indications
10.4.6.3.3 Japan: Gene Therapy Market Breakdown, by Delivery Mode
10.4.6.4 India: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.4.6.4.1 India: Gene Therapy Market Breakdown, by Vector
10.4.6.4.2 India: Gene Therapy Market Breakdown, by Indications
10.4.6.4.3 India: Gene Therapy Market Breakdown, by Delivery Mode
10.4.6.5 Australia: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.4.6.5.1 Australia: Gene Therapy Market Breakdown, by Vector
10.4.6.5.2 Australia: Gene Therapy Market Breakdown, by Indications
10.4.6.5.3 Australia: Gene Therapy Market Breakdown, by Delivery Mode
10.4.6.6 South Korea: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.4.6.6.1 South Korea: Gene Therapy Market Breakdown, by Vector
10.4.6.6.2 South Korea: Gene Therapy Market Breakdown, by Indications
10.4.6.6.3 South Korea: Gene Therapy Market Breakdown, by Delivery Mode
10.4.6.7 Rest of APAC: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.4.6.7.1 Rest of APAC: Gene Therapy Market Breakdown, by Vector
10.4.6.7.2 Rest of APAC: Gene Therapy Market Breakdown, by Indications
10.4.6.7.3 Rest of APAC: Gene Therapy Market Breakdown, by Delivery Mode
10.5 Middle East and Africa
10.5.1 Middle East and Africa Gene Therapy Market Overview
10.5.2 Middle East and Africa: Gene Therapy Market – Revenue, 2021–2031 (US$ Million)
10.5.3 Middle East and Africa: Gene Therapy Market Breakdown, by Vector
10.5.3.1 Middle East and Africa: Gene Therapy Market – Revenue and Forecast Analysis – by Vector
10.5.4 Middle East and Africa: Gene Therapy Market Breakdown, by Indications
10.5.4.1 Middle East and Africa: Gene Therapy Market – Revenue and Forecast Analysis – by Indications
10.5.5 Middle East and Africa: Gene Therapy Market Breakdown, by Delivery Mode
10.5.5.1 Middle East and Africa: Gene Therapy Market – Revenue and Forecast Analysis – by Delivery Mode
10.5.6 Middle East and Africa: Gene Therapy Market – Revenue and Forecast Analysis – by Country
10.5.6.1 Middle East and Africa: Gene Therapy Market – Revenue and Forecast Analysis – by Country
10.5.6.2 Saudi Arabia: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.5.6.2.1 Saudi Arabia: Gene Therapy Market Breakdown, by Vector
10.5.6.2.2 Saudi Arabia: Gene Therapy Market Breakdown, by Indications
10.5.6.2.3 Saudi Arabia: Gene Therapy Market Breakdown, by Delivery Mode
10.5.6.3 South Africa: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.5.6.3.1 South Africa: Gene Therapy Market Breakdown, by Vector
10.5.6.3.2 South Africa: Gene Therapy Market Breakdown, by Indications
10.5.6.3.3 South Africa: Gene Therapy Market Breakdown, by Delivery Mode
10.5.6.4 United Arab Emirates: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.5.6.4.1 United Arab Emirates: Gene Therapy Market Breakdown, by Vector
10.5.6.4.2 United Arab Emirates: Gene Therapy Market Breakdown, by Indications
10.5.6.4.3 United Arab Emirates: Gene Therapy Market Breakdown, by Delivery Mode
10.5.6.5 Rest of Middle East and Africa: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.5.6.5.1 Rest of Middle East and Africa: Gene Therapy Market Breakdown, by Vector
10.5.6.5.2 Rest of Middle East and Africa: Gene Therapy Market Breakdown, by Indications
10.5.6.5.3 Rest of Middle East and Africa: Gene Therapy Market Breakdown, by Delivery Mode
10.6 South and Central America
10.6.1 South and Central America Gene Therapy Market Overview
10.6.2 South and Central America: Gene Therapy Market – Revenue, 2021–2031 (US$ Million)
10.6.3 South and Central America: Gene Therapy Market Breakdown, by Vector
10.6.3.1 South and Central America: Gene Therapy Market – Revenue and Forecast Analysis – by Vector
10.6.4 South and Central America: Gene Therapy Market Breakdown, by Indications
10.6.4.1 South and Central America: Gene Therapy Market – Revenue and Forecast Analysis – by Indications
10.6.5 South and Central America: Gene Therapy Market Breakdown, by Delivery Mode
10.6.5.1 South and Central America: Gene Therapy Market – Revenue and Forecast Analysis – by Delivery Mode
10.6.6 South and Central America: Gene Therapy Market – Revenue and Forecast Analysis – by Country
10.6.6.1 South and Central America: Gene Therapy Market – Revenue and Forecast Analysis – by Country
10.6.6.2 Brazil: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.6.6.2.1 Brazil: Gene Therapy Market Breakdown, by Vector
10.6.6.2.2 Brazil: Gene Therapy Market Breakdown, by Indications
10.6.6.2.3 Brazil: Gene Therapy Market Breakdown, by Delivery Mode
10.6.6.3 Argentina: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.6.6.3.1 Argentina: Gene Therapy Market Breakdown, by Vector
10.6.6.3.2 Argentina: Gene Therapy Market Breakdown, by Indications
10.6.6.3.3 Argentina: Gene Therapy Market Breakdown, by Delivery Mode
10.6.6.4 Rest of South and Central America: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)
10.6.6.4.1 Rest of South and Central America: Gene Therapy Market Breakdown, by Vector
10.6.6.4.2 Rest of South and Central America: Gene Therapy Market Breakdown, by Indications
10.6.6.4.3 Rest of South and Central America: Gene Therapy Market Breakdown, by Delivery Mode
11. Competitive Landscape
11.1 Heat Map Analysis by Key Players
11.2 Company Market Share Analysis, 2024
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Merger and Acquisition
13. Company Profiles
13.1 Novartis AG
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Astellas Pharma Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Bristol-Myers Squibb Co
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Bluebird Bio Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Catalent Inc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Sanofi SA
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Daiichi Sankyo Co Ltd
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 CSL Behring LLC
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 BioMarin Pharmaceutical Inc.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Vertex Pharmaceuticals Inc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 Glossary of Terms, Gene Therapy Market
14.2 About The Insight Partners
List of Tables
Table 1. Gene Therapy Market Segmentation
Table 2. Gene Therapy Market – Revenue, 2021–2024 (US$ Million)
Table 3. Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million)
Table 4. Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector
Table 5. Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector
Table 6. Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications
Table 7. Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications
Table 8. Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode
Table 9. Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode
Table 10. North America: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector
Table 11. North America: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector
Table 12. North America: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications
Table 13. North America: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications
Table 14. North America: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode
Table 15. North America: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode
Table 16. North America: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Country
Table 17. North America: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country
Table 18. United States: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector
Table 19. United States: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector
Table 20. United States: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications
Table 21. United States: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications
Table 22. United States: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode
Table 23. United States: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode
Table 24. Canada: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector
Table 25. Canada: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector
Table 26. Canada: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications
Table 27. Canada: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications
Table 28. Canada: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode
Table 29. Canada: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode
Table 30. Mexico: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector
Table 31. Mexico: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector
Table 32. Mexico: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications
Table 33. Mexico: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications
Table 34. Mexico: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode
Table 35. Mexico: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode
Table 36. Europe: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector
Table 37. Europe: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector
Table 38. Europe: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications
Table 39. Europe: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications
Table 40. Europe: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode
Table 41. Europe: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode
Table 42. Europe: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Country
Table 43. Europe: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country
Table 44. United Kingdom: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector
Table 45. United Kingdom: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector
Table 46. United Kingdom: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications
Table 47. United Kingdom: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications
Table 48. United Kingdom: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode
Table 49. United Kingdom: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode
Table 50. Germany: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector
Table 51. Germany: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector
Table 52. Germany: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications
Table 53. Germany: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications
Table 54. Germany: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode
Table 55. Germany: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode
Table 56. France: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector
Table 57. France: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector
Table 58. France: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications
Table 59. France: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications
Table 60. France: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode
Table 61. France: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode
Table 62. Spain: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector
Table 63. Spain: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector
Table 64. Spain: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications
Table 65. Spain: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications
Table 66. Spain: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode
Table 67. Spain: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode
Table 68. Italy: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector
Table 69. Italy: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector
Table 70. Italy: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications
Table 71. Italy: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications
Table 72. Italy: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode
Table 73. Italy: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode
Table 74. Rest of Europe: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector
Table 75. Rest of Europe: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector
Table 76. Rest of Europe: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications
Table 77. Rest of Europe: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications
Table 78. Rest of Europe: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode
Table 79. Rest of Europe: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode
Table 80. Asia Pacific: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector
Table 81. Asia Pacific: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector
Table 82. Asia Pacific: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications
Table 83. Asia Pacific: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications
Table 84. Asia Pacific: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode
Table 85. Asia Pacific: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode
Table 86. Asia Pacific: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Country
Table 87. Asia Pacific: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country
Table 88. China: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector
Table 89. China: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector
Table 90. China: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications
Table 91. China: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications
Table 92. China: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode
Table 93. China: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode
Table 94. Japan: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector
Table 95. Japan: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector
Table 96. Japan: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications
Table 97. Japan: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications
Table 98. Japan: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode
Table 99. Japan: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode
Table 100. India: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector
Table 101. India: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector
Table 102. India: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications
Table 103. India: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications
Table 104. India: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode
Table 105. India: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode
Table 106. Australia: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector
Table 107. Australia: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector
Table 108. Australia: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications
Table 109. Australia: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications
Table 110. Australia: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode
Table 111. Australia: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode
Table 112. South Korea: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector
Table 113. South Korea: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector
Table 114. South Korea: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications
Table 115. South Korea: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications
Table 116. South Korea: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode
Table 117. South Korea: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode
Table 118. Rest of APAC: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector
Table 119. Rest of APAC: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector
Table 120. Rest of APAC: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications
Table 121. Rest of APAC: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications
Table 122. Rest of APAC: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode
Table 123. Rest of APAC: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode
Table 124. Middle East and Africa: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector
Table 125. Middle East and Africa: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector
Table 126. Middle East and Africa: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications
Table 127. Middle East and Africa: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications
Table 128. Middle East and Africa: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode
Table 129. Middle East and Africa: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode
Table 130. Middle East and Africa: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Country
Table 131. Middle East and Africa: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country
Table 132. Saudi Arabia: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector
Table 133. Saudi Arabia: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector
Table 134. Saudi Arabia: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications
Table 135. Saudi Arabia: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications
Table 136. Saudi Arabia: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode
Table 137. Saudi Arabia: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode
Table 138. South Africa: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector
Table 139. South Africa: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector
Table 140. South Africa: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications
Table 141. South Africa: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications
Table 142. South Africa: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode
Table 143. South Africa: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode
Table 144. United Arab Emirates: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector
Table 145. United Arab Emirates: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector
Table 146. United Arab Emirates: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications
Table 147. United Arab Emirates: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications
Table 148. United Arab Emirates: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode
Table 149. United Arab Emirates: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode
Table 150. Rest of Middle East and Africa: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector
Table 151. Rest of Middle East and Africa: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector
Table 152. Rest of Middle East and Africa: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications
Table 153. Rest of Middle East and Africa: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications
Table 154. Rest of Middle East and Africa: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode
Table 155. Rest of Middle East and Africa: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode
Table 156. South and Central America: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector
Table 157. South and Central America: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector
Table 158. South and Central America: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications
Table 159. South and Central America: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications
Table 160. South and Central America: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode
Table 161. South and Central America: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode
Table 162. South and Central America: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Country
Table 163. South and Central America: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country
Table 164. Brazil: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector
Table 165. Brazil: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector
Table 166. Brazil: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications
Table 167. Brazil: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications
Table 168. Brazil: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode
Table 169. Brazil: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode
Table 170. Argentina: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector
Table 171. Argentina: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector
Table 172. Argentina: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications
Table 173. Argentina: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications
Table 174. Argentina: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode
Table 175. Argentina: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode
Table 176. Rest of South and Central America: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector
Table 177. Rest of South and Central America: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector
Table 178. Rest of South and Central America: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications
Table 179. Rest of South and Central America: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications
Table 180. Rest of South and Central America: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode
Table 181. Rest of South and Central America: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode
Table 182. Heat Map Analysis by Key Players
List of Figures
Figure 1. Gene Therapy Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Gene Therapy Market Revenue (US$ Million), 2021–2031
Figure 5. Gene Therapy Market Share (%) – by Vector (2024 and 2031)
Figure 6. Non-Viral Vectors: Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. Viral Vectors: Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Gene Therapy Market Share (%) – by Indications (2024 and 2031)
Figure 9. Neurological Diseases: Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. Cancer: Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Duchenne Muscular Dystrophy: Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 12. Hepatological Diseases: Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. Other Indications: Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. Gene Therapy Market Share (%) – by Delivery Mode (2024 and 2031)
Figure 15. In-Vivo: Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. Ex-Vivo: Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 17. Gene Therapy Market Breakdown by Region, 2024 and 2031 (%)
Figure 18. North America: Gene Therapy Market – Revenue, 2021–2031 (US$ Million)
Figure 19. North America: Gene Therapy Market Breakdown, by Vector (2024 and 2031)
Figure 20. North America: Gene Therapy Market Breakdown, by Indications (2024 and 2031)
Figure 21. North America: Gene Therapy Market Breakdown, by Delivery Mode (2024 and 2031)
Figure 22. North America: Gene Therapy Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 23. United States: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 24. Canada: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 25. Mexico: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 26. Europe: Gene Therapy Market – Revenue, 2021–2031 (US$ Million)
Figure 27. Europe: Gene Therapy Market Breakdown, by Vector (2024 and 2031)
Figure 28. Europe: Gene Therapy Market Breakdown, by Indications (2024 and 2031)
Figure 29. Europe: Gene Therapy Market Breakdown, by Delivery Mode (2024 and 2031)
Figure 30. Europe: Gene Therapy Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 31. United Kingdom: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 32. Germany: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 33. France: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 34. Spain: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 35. Italy: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 36. Rest of Europe: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 37. Asia Pacific: Gene Therapy Market – Revenue, 2021–2031 (US$ Million)
Figure 38. Asia Pacific: Gene Therapy Market Breakdown, by Vector (2024 and 2031)
Figure 39. Asia Pacific: Gene Therapy Market Breakdown, by Indications (2024 and 2031)
Figure 40. Asia Pacific: Gene Therapy Market Breakdown, by Delivery Mode (2024 and 2031)
Figure 41. Asia Pacific: Gene Therapy Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 42. China: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 43. Japan: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 44. India: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 45. Australia: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 46. South Korea: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 47. Rest of APAC: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 48. Middle East and Africa: Gene Therapy Market – Revenue, 2021–2031 (US$ Million)
Figure 49. Middle East and Africa: Gene Therapy Market Breakdown, by Vector (2024 and 2031)
Figure 50. Middle East and Africa: Gene Therapy Market Breakdown, by Indications (2024 and 2031)
Figure 51. Middle East and Africa: Gene Therapy Market Breakdown, by Delivery Mode (2024 and 2031)
Figure 52. Middle East and Africa: Gene Therapy Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 53. Saudi Arabia: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 54. South Africa: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 55. United Arab Emirates: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 56. Rest of Middle East and Africa: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 57. South and Central America: Gene Therapy Market – Revenue, 2021–2031 (US$ Million)
Figure 58. South and Central America: Gene Therapy Market Breakdown, by Vector (2024 and 2031)
Figure 59. South and Central America: Gene Therapy Market Breakdown, by Indications (2024 and 2031)
Figure 60. South and Central America: Gene Therapy Market Breakdown, by Delivery Mode (2024 and 2031)
Figure 61. South and Central America: Gene Therapy Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 62. Brazil: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 63. Argentina: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 64. Rest of South and Central America: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 65. Company Market Share Analysis, 2024
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For